219 related articles for article (PubMed ID: 23764768)
21. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
Hewitt KM; Sharma PK; Samowitz W; Hobbs M
Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
27. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
28. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
Takeuchi H; Greep NC; Hoon DS; Giuliano AE; Hansen NM; Umetani N; Singer FR
J Clin Endocrinol Metab; 2007 May; 92(5):1785-90. PubMed ID: 17299072
[TBL] [Abstract][Full Text] [Related]
30. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
31. Evidence of a functional estrogen receptor in parathyroid adenomas.
Haglund F; Ma R; Huss M; Sulaiman L; Lu M; Nilsson IL; Höög A; Juhlin CC; Hartman J; Larsson C
J Clin Endocrinol Metab; 2012 Dec; 97(12):4631-9. PubMed ID: 23024189
[TBL] [Abstract][Full Text] [Related]
32. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas.
Fu X; Li J; Li K; Tian X; Zhang Y
Histopathology; 2009 Nov; 55(5):554-63. PubMed ID: 19912361
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiles in parathyroid adenoma and normal parathyroid tissue.
Kim SW
Vitam Horm; 2022; 120():289-304. PubMed ID: 35953114
[TBL] [Abstract][Full Text] [Related]
35. Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors.
Zhang HY; Rumilla KM; Jin L; Nakamura N; Stilling GA; Ruebel KH; Hobday TJ; Erlichman C; Erickson LA; Lloyd RV
Endocrine; 2006 Dec; 30(3):299-306. PubMed ID: 17526942
[TBL] [Abstract][Full Text] [Related]
36. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
[TBL] [Abstract][Full Text] [Related]
37. Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.
Juhlin CC; Nilsson IL; Johansson K; Haglund F; Villablanca A; Höög A; Larsson C
Endocr Pathol; 2010 Sep; 21(3):166-77. PubMed ID: 20473645
[TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.
Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L
Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343
[TBL] [Abstract][Full Text] [Related]
39. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.
Beta M; Chitipothu S; Khetan V; Biswas J; Krishnakumar S
Curr Eye Res; 2015 Jul; 40(7):719-28. PubMed ID: 25207834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
